Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. It operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and a range of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products. It also operates retail clinics that provide treatment for common conditions; and a range of preventive services comprising screenings, medical tests, immunizations, and basic physical exams. In addition, this segment offers healthcare coaching and disease management services. The Pharmacy Services segment provides pharmacy benefit management (PBM) services and a range of pharmacy-related services. This segment also performs prescription adjudication services for other PBMs; and offers integrated mail-order, specialty and compounding pharmacy, and infertility treatment services, as well as drug benefits under the federal government's Medicare Part D program. As of April 12, 2018, the company operated approximately 2,548 stores in 19 states. Rite Aid Corporation was founded in 1927 and is headquartered in Camp Hill, Pennsylvania.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
SectorRetail/Wholesale
SymbolNYSE:RAD
CUSIP76775410
Phone717-761-2633
Debt
Debt-to-Equity Ratio1.75
Current Ratio1.49
Quick Ratio0.85
Price-To-Earnings
Trailing P/E Ratio-69.50
Forward P/E Ratio36.50
P/E GrowthN/A
Sales & Book Value
Annual Sales$21.53 billion
Price / Sales0.07
Cash Flow$0.5794 per share
Price / Cash2.52
Book Value$1.50 per share
Price / Book0.97
Profitability
EPS (Most Recent Fiscal Year)($0.02)
Net Income$943.47 million
Net Margins5.18%
Return on Equity-2.88%
Return on Assets-0.36%
Miscellaneous
Employees59,000
Outstanding Shares1,066,810,000
Market Cap$1.58 billion
Rite Aid (NYSE:RAD) Frequently Asked Questions
What is Rite Aid's stock symbol?
Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."
How were Rite Aid's earnings last quarter?
Rite Aid Co. (NYSE:RAD) released its quarterly earnings results on Wednesday, June, 27th. The company reported ($0.01) EPS for the quarter, missing the Zacks' consensus estimate of ($0.01) by $0.00. The business had revenue of $5.39 billion for the quarter, compared to the consensus estimate of $5.32 billion. Rite Aid had a negative return on equity of 2.88% and a net margin of 5.18%. The firm's revenue was down .9% on a year-over-year basis. During the same quarter last year, the company earned ($0.05) earnings per share. View Rite Aid's Earnings History.
When is Rite Aid's next earnings date?
What guidance has Rite Aid issued on next quarter's earnings?
Rite Aid issued an update on its FY19 earnings guidance on Wednesday, June, 27th. The company provided EPS guidance of $0.02-0.06 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.04. The company issued revenue guidance of $21.70-22.10 billion, compared to the consensus revenue estimate of $21.65 billion.
What price target have analysts set for RAD?
7 brokerages have issued 1-year price objectives for Rite Aid's stock. Their predictions range from $1.50 to $6.00. On average, they expect Rite Aid's share price to reach $2.5357 in the next twelve months. This suggests a possible upside of 73.7% from the stock's current price. View Analyst Price Targets for Rite Aid.
What is the consensus analysts' recommendation for Rite Aid?
7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rite Aid in the last year. There are currently 1 sell rating and 6 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Rite Aid.
Are investors shorting Rite Aid?
Rite Aid saw a decrease in short interest during the month of July. As of July 31st, there was short interest totalling 174,943,256 shares, a decrease of 3.3% from the July 13th total of 180,954,193 shares. Based on an average daily trading volume, of 10,735,233 shares, the short-interest ratio is presently 16.3 days. Approximately 16.6% of the company's shares are sold short. View Rite Aid's Current Options Chain.
Who are some of Rite Aid's key competitors?
Who are Rite Aid's key executives?
Rite Aid's management team includes the folowing people:
- Mr. John T. Standley, Chairman & CEO (Age 55)
- Mr. Kermit Ray Crawford, Pres & COO (Age 59)
- Mr. Darren Wayne Karst, Sr. Exec. VP, CFO & Chief Admin. Officer (Age 58)
- Ms. Jocelyn Zazyczny Konrad, Exec. VP of Pharmacy (Age 48)
- Mr. Bryan Everett, Chief Operating Officer of Rite Aid Stores (Age 45)
Has Rite Aid been receiving favorable news coverage?
News articles about RAD stock have been trending somewhat positive on Friday, according to Accern Sentiment Analysis. The research group identifies positive and negative news coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Rite Aid earned a media and rumor sentiment score of 0.14 on Accern's scale. They also assigned news headlines about the company an impact score of 49.50 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near term. View Recent Headlines for Rite Aid.
Who are Rite Aid's major shareholders?
Rite Aid's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp (2.12%), Alpine Associates Management Inc. (1.27%), IndexIQ Advisors LLC (0.74%), Schwab Charles Investment Management Inc. (0.67%), Private Management Group Inc. (0.62%) and Private Management Group Inc. (0.62%). View Institutional Ownership Trends for Rite Aid.
Which major investors are selling Rite Aid stock?
RAD stock was sold by a variety of institutional investors in the last quarter, including California Public Employees Retirement System, State Board of Administration of Florida Retirement System, Verition Fund Management LLC, First Trust Advisors LP, Gabelli Funds LLC, Creative Planning, Alpine Global Management LLC and NJ State Employees Deferred Compensation Plan. View Insider Buying and Selling for Rite Aid.
Which major investors are buying Rite Aid stock?
RAD stock was bought by a variety of institutional investors in the last quarter, including Private Management Group Inc., Private Management Group Inc., Sarbit Advisory Services Inc., Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp, Alpine Associates Management Inc., Schwab Charles Investment Management Inc., Commonwealth of Pennsylvania Public School Empls Retrmt SYS and Bank of New York Mellon Corp. View Insider Buying and Selling for Rite Aid.
How do I buy shares of Rite Aid?
Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Rite Aid's stock price today?
One share of RAD stock can currently be purchased for approximately $1.46.
How big of a company is Rite Aid?
Rite Aid has a market capitalization of $1.58 billion and generates $21.53 billion in revenue each year. The company earns $943.47 million in net income (profit) each year or ($0.02) on an earnings per share basis. Rite Aid employs 59,000 workers across the globe.
How can I contact Rite Aid?
Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17105. The company can be reached via phone at 717-761-2633 or via email at [email protected]
MarketBeat Community Rating for Rite Aid (NYSE RAD)
MarketBeat's community ratings are surveys of what our community members think about Rite Aid and other stocks. Vote "Outperform" if you believe RAD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RAD will underperform the S&P 500 over the long term. You may vote once every thirty days.
